-
1
-
-
0017174101
-
Polycythemia vera: Stem-cell and probable clonal origin of the disease
-
Adamson JW, Fialkow PJ, Murphy S, Prchal JF, Steinmann L. Polycythemia vera: stem-cell and probable clonal origin of the disease. N Engl J Med 1976 295 : 913 6.
-
(1976)
N Engl J Med
, vol.295
, pp. 913-916
-
-
Adamson, J.W.1
Fialkow, P.J.2
Murphy, S.3
Prchal, J.F.4
Steinmann, L.5
-
2
-
-
2442677685
-
The chronic myeloproliferative disorders: Clonality and clinical heterogeneity
-
Spivak JL. The chronic myeloproliferative disorders: clonality and clinical heterogeneity. Semin Hematol 2004 41 (Suppl. 3 1 5.
-
(2004)
Semin Hematol
, vol.41
, Issue.3
, pp. 1-5
-
-
Spivak, J.L.1
-
3
-
-
0019818299
-
Evidence that essential thrombocythemia is a clonal disorder with origin in a multipotent stem cell
-
Fialkow PJ, Faguet GB, Jacobson RJ, Vaidya K, Murphy S. Evidence that essential thrombocythemia is a clonal disorder with origin in a multipotent stem cell. Blood 1981 58 : 916 9.
-
(1981)
Blood
, vol.58
, pp. 916-919
-
-
Fialkow, P.J.1
Faguet, G.B.2
Jacobson, R.J.3
Vaidya, K.4
Murphy, S.5
-
4
-
-
17844383458
-
A unique clonal JAK2 mutation leading to constitutive signalling causes polycythaemia vera
-
James C, Ugo V, Le Couedic JP, et al. A unique clonal JAK2 mutation leading to constitutive signalling causes polycythaemia vera. Nature 2005 434 : 1144 8.
-
(2005)
Nature
, vol.434
, pp. 1144-1148
-
-
James, C.1
Ugo, V.2
Le Couedic, J.P.3
-
5
-
-
20144363192
-
Acquired mutation of the tyrosine kinase JAK2 in human myeloproliferative disorders
-
Baxter EJ, Scott LM, Campbell PJ, et al. Acquired mutation of the tyrosine kinase JAK2 in human myeloproliferative disorders. Lancet 2005 365 : 1054 61.
-
(2005)
Lancet
, vol.365
, pp. 1054-1061
-
-
Baxter, E.J.1
Scott, L.M.2
Campbell, P.J.3
-
6
-
-
17644424955
-
A gain-of-function mutation of JAK2 in myeloproliferative disorders
-
Kralovics R, Passamonti F, Buser AS, Teo SS, Tiedt R, Passweg JR, Tichelli A, Cazzola M, Skoda RC. A gain-of-function mutation of JAK2 in myeloproliferative disorders. N Engl J Med 2005 352 : 1779 90.
-
(2005)
N Engl J Med
, vol.352
, pp. 1779-1790
-
-
Kralovics, R.1
Passamonti, F.2
Buser, A.S.3
Teo, S.S.4
Tiedt, R.5
Passweg, J.R.6
Tichelli, A.7
Cazzola, M.8
Skoda, R.C.9
-
7
-
-
38349101871
-
Classification and diagnosis of myeloproliferative neoplasms: The 2008 World Health Organization criteria and point-of-care diagnostic algorithms
-
Tefferi A, Vardiman JW. Classification and diagnosis of myeloproliferative neoplasms: The 2008 World Health Organization criteria and point-of-care diagnostic algorithms. Leukemia 2008 22 : 14 22.
-
(2008)
Leukemia
, vol.22
, pp. 14-22
-
-
Tefferi, A.1
Vardiman, J.W.2
-
8
-
-
33751234537
-
Report on two novel nucleotide exchanges in the JAK2 pseudokinase domain: D620E and E627E
-
Schnittger S, Bacher U, Kern W, Schröder M, Haferlach T, Schoch C. Report on two novel nucleotide exchanges in the JAK2 pseudokinase domain: D620E and E627E. Leukemia 2006 20 : 2195 7.
-
(2006)
Leukemia
, vol.20
, pp. 2195-2197
-
-
Schnittger, S.1
Bacher, U.2
Kern, W.3
Schröder, M.4
Haferlach, T.5
Schoch, C.6
-
9
-
-
33751246214
-
Detection of a new JAK2 D620E mutation in addition to V617F in a patient with polycythemia vera
-
Grunebach F, Bross-Bach U, Kanz L, Brossart P. Detection of a new JAK2 D620E mutation in addition to V617F in a patient with polycythemia vera. Leukemia 2006 20 : 2210 1.
-
(2006)
Leukemia
, vol.20
, pp. 2210-2211
-
-
Grunebach, F.1
Bross-Bach, U.2
Kanz, L.3
Brossart, P.4
-
10
-
-
58849118941
-
Mutation profile of JAK2 transcripts in patients with chronic myeloproliferative neoplasias
-
Ma W, Kantarjian H, Zhang X, Yeh CH, Zhang ZJ, Verstovsek S, Albitar M. Mutation profile of JAK2 transcripts in patients with chronic myeloproliferative neoplasias. J Mol Diagn 2009 11 : 49 53.
-
(2009)
J Mol Diagn
, vol.11
, pp. 49-53
-
-
Ma, W.1
Kantarjian, H.2
Zhang, X.3
Yeh, C.H.4
Zhang, Z.J.5
Verstovsek, S.6
Albitar, M.7
-
11
-
-
38949160429
-
Somatic mutations of JAK2 exon 12 in patients with JAK2 (V617F)-negative myeloproliferative disorders
-
Pietra D, Li S, Brisci A, et al. Somatic mutations of JAK2 exon 12 in patients with JAK2 (V617F)-negative myeloproliferative disorders. Blood 2008 111 : 1686 9.
-
(2008)
Blood
, vol.111
, pp. 1686-1689
-
-
Pietra, D.1
Li, S.2
Brisci, A.3
-
12
-
-
33846660947
-
JAK2 exon 12 mutations in polycythemia vera and idiopathic erythrocytosis
-
Scott LM, Tong W, Levine RL, et al. JAK2 exon 12 mutations in polycythemia vera and idiopathic erythrocytosis. N Engl J Med 2007 356 : 459 68.
-
(2007)
N Engl J Med
, vol.356
, pp. 459-468
-
-
Scott, L.M.1
Tong, W.2
Levine, R.L.3
-
13
-
-
62949227518
-
Detection of JAK2 exon 12 mutations in 15 patients with JAK2V617F negative polycythemia vera
-
Schnittger S, Bacher U, Haferlach C, et al. Detection of JAK2 exon 12 mutations in 15 patients with JAK2V617F negative polycythemia vera. Haematologica 2009 94 : 414 8.
-
(2009)
Haematologica
, vol.94
, pp. 414-418
-
-
Schnittger, S.1
Bacher, U.2
Haferlach, C.3
-
14
-
-
33748684367
-
The JAK2-V617F mutation is frequently present at diagnosis in patients with essential thrombocythemia and polycythemia vera
-
Lippert E, Boissinot M, Kralovics R, Girodon F, Dobo I, Praloran V, Boiret-Dupré N, Skoda RC, Hermouet S. The JAK2-V617F mutation is frequently present at diagnosis in patients with essential thrombocythemia and polycythemia vera. Blood 2006 108 : 1865 7.
-
(2006)
Blood
, vol.108
, pp. 1865-1867
-
-
Lippert, E.1
Boissinot, M.2
Kralovics, R.3
Girodon, F.4
Dobo, I.5
Praloran, V.6
Boiret-Dupré, N.7
Skoda, R.C.8
Hermouet, S.9
-
15
-
-
34249876924
-
Correlations of JAK2-V617F mutation with clinical and laboratory findings in patients with myeloproliferative disorders
-
Speletas M, Katodritou E, Daiou C, Mandala E, Papadakis E, Kioumi A, Ritis K, Korantzis I. Correlations of JAK2-V617F mutation with clinical and laboratory findings in patients with myeloproliferative disorders. Leuk Res 2007 31 : 1053 62.
-
(2007)
Leuk Res
, vol.31
, pp. 1053-1062
-
-
Speletas, M.1
Katodritou, E.2
Daiou, C.3
Mandala, E.4
Papadakis, E.5
Kioumi, A.6
Ritis, K.7
Korantzis, I.8
-
16
-
-
0034871732
-
RNase cleavage-based methods for mutationSNP detection, past and present
-
Goldrick MM. RNase cleavage-based methods for mutationSNP detection, past and present. Hum Mutat 2001 18 : 190 204.
-
(2001)
Hum Mutat
, vol.18
, pp. 190-204
-
-
Goldrick, M.M.1
-
17
-
-
0029657862
-
NIRCA: A rapid robust method for screening for unknown point mutations
-
Goldrick MM, Kimball GR, Liu Q, Martin LA, Sommer SS, Tseng JY. NIRCA: a rapid robust method for screening for unknown point mutations. BioTechniques 1996 21 : 106 12.
-
(1996)
BioTechniques
, vol.21
, pp. 106-112
-
-
Goldrick, M.M.1
Kimball, G.R.2
Liu, Q.3
Martin, L.A.4
Sommer, S.S.5
Tseng, J.Y.6
-
18
-
-
11144354882
-
Non-isotopic RNase cleavage assay for mutation detection in MEFV, the gene responsible for familial Mediterranean fever, in a cohort of Greek patients
-
Ritis K, Giaglis S, Spathari N, et al. Non-isotopic RNase cleavage assay for mutation detection in MEFV, the gene responsible for familial Mediterranean fever, in a cohort of Greek patients. Ann Rheum Dis 2004 63 : 438 43.
-
(2004)
Ann Rheum Dis
, vol.63
, pp. 438-443
-
-
Ritis, K.1
Giaglis, S.2
Spathari, N.3
-
19
-
-
7344262556
-
Absence of Bruton's tyrosine kinase (Btk) mutations in patients with acute myeloid leukaemia
-
Ritis K, Speletas M, Tsironidou V, et al. Absence of Bruton's tyrosine kinase (Btk) mutations in patients with acute myeloid leukaemia. Br J Haematol 1998 102 : 1241 8.
-
(1998)
Br J Haematol
, vol.102
, pp. 1241-1248
-
-
Ritis, K.1
Speletas, M.2
Tsironidou, V.3
|